Literature DB >> 16752937

Long-term treatment with atypical antipsychotics and risk of weight gain.

Emmanuel Stip, Karyne Anselmo, Marcel Wolfe, Christiane Lessard, Pierre Landry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16752937     DOI： 10.2165/00002018-200629060-00009

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  8 in total

1.  Weight loss after switching from conventional olanzapine tablets to orally disintegrating olanzapine tablets.

Authors:  Lieuwe de Haan; Therese van Amelsvoort; Kim Rosien; Don Linszen
Journal:  Psychopharmacology (Berl)       Date:  2004-09       Impact factor: 4.530

2.  Pharmacokinetics of olanzapine after single-dose oral administration of standard tablet versus normal and sublingual administration of an orally disintegrating tablet in normal volunteers.

Authors:  John S Markowitz; C Lindsay DeVane; Robert J Malcolm; Holly A Gefroh; Jun-Sheng Wang; Hao-Jie Zhu; Jennifer L Donovan
Journal:  J Clin Pharmacol       Date:  2006-02       Impact factor: 3.126

3.  Olanzapine: a novel atypical neuroleptic agent.

Authors:  V I Reus
Journal:  Lancet       Date:  1997-05-03       Impact factor: 79.321

4.  Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

Authors:  Jeffrey A Lieberman; T Scott Stroup; Joseph P McEvoy; Marvin S Swartz; Robert A Rosenheck; Diana O Perkins; Richard S E Keefe; Sonia M Davis; Clarence E Davis; Barry D Lebowitz; Joanne Severe; John K Hsiao
Journal:  N Engl J Med       Date:  2005-09-19       Impact factor: 91.245

Review 5.  Long-term treatment with atypical antipsychotics and the risk of weight gain : a literature analysis.

Authors:  Salvatore Gentile
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

6.  Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor.

Authors:  L Rauser; J E Savage; H Y Meltzer; B L Roth
Journal:  J Pharmacol Exp Ther       Date:  2001-10       Impact factor: 4.030

7.  Serotonin contracts the isolated rat pylorus via a 5-HT2-like receptor.

Authors:  K Eberle-Wang; B T Braun; K J Simansky
Journal:  Am J Physiol       Date:  1994-01

8.  Olanzapine orally disintegrating tablets in the treatment of acutely ill non-compliant patients with schizophrenia.

Authors:  Bruce J Kinon; Angela L Hill; Hong Liu; Sara Kollack-Walker
Journal:  Int J Neuropsychopharmacol       Date:  2003-06       Impact factor: 5.176
  8 in total
  1 in total

1.  Orally disintegrating olanzapine review: effectiveness, patient preference, adherence, and other properties.

Authors:  William Montgomery; Tamas Treuer; Jamie Karagianis; Haya Ascher-Svanum; Gavan Harrison
Journal:  Patient Prefer Adherence       Date:  2012-02-01       Impact factor: 2.711
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.